Search Results - "Funke, V"

Refine Results
  1. 1

    Haploidentical BMT and post-transplant Cy for severe aplastic anemia: a multicenter retrospective study by Esteves, I, Bonfim, C, Pasquini, R, Funke, V, Pereira, N F, Rocha, V, Novis, Y, Arrais, C, Colturato, V, de Souza, M P, Torres, M, Fernandes, J F, Kerbauy, F R, Ribeiro, A A F, Santos, F P S, Hamerschlak, N

    Published in Bone marrow transplantation (Basingstoke) (01-05-2015)
    “…Patients with refractory severe aplastic anemia (SAA) who lack a matched sibling or unrelated donor need new therapeutic approaches. Hematopoietic SCT (HSCT)…”
    Get full text
    Journal Article
  2. 2

    Bronchiolitis obliterans in patients undergoing allogeneic hematopoietic SCT by Vieira, A G, Funke, V A M, Nunes, E C, Frare, R, Pasquini, R

    Published in Bone marrow transplantation (Basingstoke) (01-06-2014)
    “…Bronchiolitis obliterans (BO) is a severe pulmonary complication of allo-SCT. This study evaluated the incidence of BO in patients undergoing allo-SCT in…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5

    Risks for infection of strawberry plants with an aerosolized inoculum of Xanthomonas fragariae by van der Wolf, J. M., Evenhuis, A., Kastelein, P., Krijger, M. C., Funke, V. Z., van den Berg, W., Moene, A. F.

    “…Xanthomonas fragariae is the causative agent of angular leaf spot of strawberry, a quarantine organism in plant propagation material in the European Union…”
    Get full text
    Journal Article
  6. 6

    Safety and potential efficacy of low-dose methotrexate for treatment of chronic graft-versus-host disease by GIACCONE, L, MARTIN, P, CARPENTER, P, MORAVEC, C, HOOPER, H, FUNKE, V. A. M, STORB, R, FLOWERS, M. E. D

    Published in Bone marrow transplantation (Basingstoke) (01-08-2005)
    “…Low-dose methotrexate (MTX) is widely used in autoimmune diseases because of its anti-inflammatory activity. We report here the results of a retrospective…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9

    Therapy for severe refractory acute graft-versus-host disease with basiliximab, a selective interleukin-2 receptor antagonist by FUNKE, V. A. M, DE MEDEIROS, C. R, SETUBAL, D. C, RUIZ, J, BITENCOURT, M. A, BONFIM, C. M, NETO, J. Z, PASQUINI, R

    Published in Bone marrow transplantation (Basingstoke) (01-05-2006)
    “…Basiliximab is a chimeric monoclonal antibody that binds to the alpha chain of IL-2R on activated cytotoxic T-cells, inhibiting lymphocyte proliferation. We…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Imatinib mesylate versus allogeneic BMT for patients with chronic myeloid leukemia in first chronic phase by Bittencourt, H, Funke, V, Fogliatto, L, Magalhães, S, Setubal, D, Paz, A, Macedo, A V, Ruiz, J, Azambuja, A P, Silla, L, Clementino, N, Pasquini, R

    Published in Bone marrow transplantation (Basingstoke) (01-11-2008)
    “…Imatinib mesylate (IM) is now first-line treatment for CML. To study the results of treatment with IM after IFN failure/intolerance versus allogeneic BMT…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20